News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
517,551 Results
Type
Article (38261)
Company Profile (339)
Press Release (478941)
Multimedia
Podcasts (116)
Webinars (15)
Section
Business (142675)
Career Advice (1404)
Deals (27748)
Drug Delivery (120)
Drug Development (73451)
Employer Resources (117)
FDA (11861)
Job Trends (10542)
News (259890)
Policy (28022)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (2148)
Accelerated approval (34)
Adcomms (31)
Allergies (135)
Alliances (45858)
ALS (157)
Alzheimer's disease (1624)
Antibody-drug conjugate (ADC) (323)
Approvals (12028)
Artificial intelligence (443)
Autoimmune disease (160)
Automation (28)
Bankruptcy (266)
Best Places to Work (8794)
BIOSECURE Act (17)
Biosimilars (174)
Biotechnology (251)
Bladder cancer (146)
Brain cancer (63)
Breast cancer (556)
Cancer (4458)
Cardiovascular disease (367)
Career advice (1199)
Career pathing (27)
CAR-T (276)
CDC (59)
Cell therapy (725)
Cervical cancer (34)
Clinical research (62468)
Collaboration (1663)
Company closure (3)
Compensation (1098)
Complete response letters (69)
COVID-19 (2701)
CRISPR (96)
C-suite (710)
Cystic fibrosis (141)
Data (5775)
Decentralized trials (1)
Denatured (22)
Depression (132)
Diabetes (460)
Diagnostics (4326)
Digital health (28)
Diversity (8)
Diversity, equity & inclusion (37)
Drug discovery (249)
Drug pricing (190)
Drug shortages (32)
Duchenne muscular dystrophy (239)
Earnings (54434)
Editorial (60)
Employer branding (14)
Employer resources (111)
Events (75729)
Executive appointments (771)
FDA (14590)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1309)
Gene editing (204)
Generative AI (40)
Gene therapy (607)
GLP-1 (1000)
Government (4554)
Grass and pollen (6)
Guidances (324)
Healthcare (13719)
HIV (58)
Huntington's disease (49)
IgA nephropathy (82)
Immunology and inflammation (264)
Immuno-oncology (61)
Indications (105)
Infectious disease (2992)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (121)
Intellectual property (223)
Interviews (242)
IPO (12818)
IRA (53)
Job creations (2115)
Job search strategy (1010)
JPM (54)
Kidney cancer (13)
Labor market (56)
Layoffs (445)
Leadership (25)
Legal (7334)
Liver cancer (77)
Longevity (15)
Lung cancer (607)
Lymphoma (353)
Machine learning (41)
Management (36)
Manufacturing (691)
MASH (172)
Medical device (7485)
Medtech (7518)
Mergers & acquisitions (15902)
Metabolic disorders (1258)
Multiple sclerosis (155)
NASH (22)
Neurodegenerative disease (314)
Neuropsychiatric disorders (93)
Neuroscience (2831)
Neurotech (1)
NextGen: Class of 2026 (4537)
Non-profit (3138)
Now hiring (34)
Obesity (624)
Opinion (273)
Ovarian cancer (155)
Pain (160)
Pancreatic cancer (212)
Parkinson's disease (276)
Partnered (27)
Patents (442)
Patient recruitment (437)
Peanut (56)
People (39779)
Pharmaceutical (56)
Pharmacy benefit managers (23)
Phase 1 (19913)
Phase 2 (27657)
Phase 3 (20519)
Pipeline (4885)
Policy (301)
Postmarket research (2035)
Preclinical (8495)
Press Release (44)
Prostate cancer (219)
Psychedelics (55)
Radiopharmaceuticals (291)
Rare diseases (867)
Real estate (3311)
Recruiting (53)
Regulatory (20374)
Reports (30)
Research institute (1970)
Resumes & cover letters (208)
Rett syndrome (28)
RNA editing (21)
RSV (86)
Schizophrenia (149)
Series A (216)
Series B (167)
Service/supplier (3)
Sickle cell disease (99)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (33)
Startups (2774)
State (1)
Stomach cancer (15)
Supply chain (88)
Tariffs (76)
The Weekly (93)
Vaccines (1101)
Venture capital (87)
Weight loss (412)
Women's health (65)
Worklife (13)
Date
Today (43)
Last 7 days (455)
Last 30 days (1904)
Last 365 days (25648)
2026 (3292)
2025 (25998)
2024 (29538)
2023 (32865)
2022 (42105)
2021 (45098)
2020 (41715)
2019 (33750)
2018 (25326)
2017 (24806)
2016 (23021)
2015 (26825)
2014 (20473)
2013 (16335)
2012 (17008)
2011 (17646)
2010 (16406)
Location
Africa (620)
Alabama (77)
Alaska (5)
Arizona (166)
Arkansas (8)
Asia (32321)
Australia (5717)
California (9474)
Canada (2737)
China (1027)
Colorado (359)
Connecticut (394)
Delaware (313)
Europe (75858)
Florida (1346)
Georgia (299)
Hawaii (4)
Idaho (39)
Illinois (651)
India (64)
Indiana (392)
Iowa (20)
Japan (398)
Kansas (102)
Kentucky (28)
Louisiana (21)
Maine (37)
Maryland (1204)
Massachusetts (7148)
Michigan (193)
Minnesota (401)
Mississippi (3)
Missouri (89)
Montana (27)
Nebraska (12)
Nevada (94)
New Hampshire (40)
New Jersey (2625)
New Mexico (20)
New York (2506)
North Carolina (1177)
North Dakota (7)
Northern California (4646)
Ohio (249)
Oklahoma (14)
Oregon (29)
Pennsylvania (1810)
Puerto Rico (19)
Rhode Island (32)
South America (859)
South Carolina (36)
South Dakota (1)
Southern California (3729)
Tennessee (103)
Texas (1308)
United States (33012)
Utah (200)
Vermont (1)
Virginia (227)
Washington D.C. (56)
Washington State (750)
West Virginia (3)
Wisconsin (85)
Wyoming (2)
517,551 Results for "affimed therapeutics ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
December 18, 2025
·
3 min read
Press Releases
Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
February 9, 2026
·
3 min read
Press Releases
Outlook Therapeutics Expands European Footprint with Exclusive Commercial Distribution Agreement with Mediconsult AG for LYTENAVA™ (bevacizumab gamma) in Switzerland
February 19, 2026
·
7 min read
Press Releases
Shield Therapeutics Announces FDA Approval of ACCRUFeR®, the First and Only Prescription Oral Iron Therapy Approved for Children Age 10 and Older
February 17, 2026
·
2 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
·
5 min read
Press Releases
Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes
January 9, 2026
·
3 min read
Press Releases
Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation
February 20, 2026
·
1 min read
Press Releases
Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging
February 5, 2026
·
7 min read
Startups
Six Startups Changing The Way We Age
Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these six biotechs are playing in the largely underappreciated longevity space, developing therapies that may improve the quality of aging.
July 9, 2025
·
11 min read
·
Tristan Manalac
Press Releases
Cellular Telomere Extension Technology: Can It Become a Core Platform for the Anti-Aging Industry? - Commentary by Unexakorea
February 13, 2026
·
1 min read
1 of 51,756
Next
